Aeterna Zentaris: Poster on Diagnostic Use of Oral Synthetic Growth Hormone Secretagogue/Ghrelin Receptor Agonist, AEZS-130 (Macimorelin, Solorel(TM)) to be Presented at Upcoming 5th International Congress of the GRS-IGF Society in New York
President and CEO,
Poster Title: "AEZS-30 (Macimorelin, Solorel (TM)) an Oral Ghrelin Mimetic GH Secretagogue, as a Potential Diagnostic Test for Adult GH Deficiency", Biller, Beverly M.K., M.D., K.C.J. Yuen, V. Bonert, M. Chen, A. Dobs, J.M. Garcia, M. Kipnes, M. Molitch, R. Swerdloff, C. Wang, D. Cook, I.R. Altemose, G.R. Merriam Presenter: Beverly M.K. Biller, M.D, Harvard Medical School/Massachusetts General Hospital, Boston, MA Date and Time: Tuesday, October 5, 2010 from 1:00 p.m. to 2:00 p.m. (eastern) Poster Board #: 3 Location: Metropolitan Ballroom West, Sheraton New York Hotel, New York
The Company also announced that its President and CEO,
About Aeterna Zentaris Inc.
Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.